Conmed

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Conmed and other ETFs, options, and stocks.

About CNMD

CONMED Corp. is a medical technology company, which engages in providing devices and equipment for surgical procedures. Its products include AirSeal and insufflation, allograft cartilage and tissue, arthroplasty, biliary and endoscopic ultrasound, biomedical sensors and electrodes, biopsy and polypectomy, dilators and accessories, electrosurgical units, fixation devices, hemostasis, implants and suture anchors, infection prevention, patient positioning, and related products. 

CEO
Patrick Joseph Beyer
CEOPatrick Joseph Beyer
Employees
3,900
Employees3,900
Headquarters
Largo, Florida
HeadquartersLargo, Florida
Founded
1970
Founded1970
Employees
3,900
Employees3,900

CNMD Key Statistics

Market cap
1.14B
Market cap1.14B
Price-Earnings ratio
24.72
Price-Earnings ratio24.72
Dividend yield
2.14%
Dividend yield2.14%
Average volume
416.85K
Average volume416.85K
High today
$37.45
High today$37.45
Low today
$36.76
Low today$36.76
Open price
$37.11
Open price$37.11
Volume
163.92K
Volume163.92K
52 Week high
$61.28
52 Week high$61.28
52 Week low
$35.37
52 Week low$35.37

Stock Snapshot

The current Conmed(CNMD) stock price is $37.06, with a market capitalization of 1.14B. The stock trades at a price-to-earnings (P/E) ratio of 24.72 and offers a dividend yield of 2.1%.

On 2026-03-18, Conmed(CNMD) stock moved within a range of $36.76 to $37.45. With shares now at $37.06, the stock is trading +0.8% above its intraday low and -1.1% below the session's peak.

Trading activity shows a volume of 163.92K, compared to an average daily volume of 416.85K.

Over the past 52 weeks, Conmed(CNMD) stock has traded between a high of $61.28 and a low of $35.37.

Over the past 52 weeks, Conmed(CNMD) stock has traded between a high of $61.28 and a low of $35.37.

CNMD News

TipRanks 1d
Conmed downgraded to Neutral from Overweight at Piper Sandler

Piper Sandler analyst Matt O’Brien downgraded Conmed (CNMD) to Neutral from Overweight with a price target of $39, down from $55. The company’s AirSeal “did not...

TipRanks 5d
Conmed Names Andrew Moller Interim Principal Financial Officer

Conmed ( (CNMD) ) has provided an update. On March 13, 2026, CONMED Corporation announced that Andrew Moller, 51, will be appointed Interim Principal Financial...

Analyst ratings

100%

of 6 ratings
Buy
0%
Hold
100%
Sell
0%

People also own

Based on the portfolios of people who own CNMD. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.